CAre of Patients With PArenteral Nutrition At Home
CAPANAH
Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate the Quality of Care for Adult Patients on Home Parenteral Nutrition (HPN)
1 other identifier
observational
39
1 country
13
Brief Summary
This research aims to give an overview of a number of aspects related to the quality of care for adult patients on home parenteral nutrition. Concretely this study follows up different aspects on different moments in the care of the patient pathways:
- process indicators concerning indication, parenteral nutrition, training, team access roads and the succession of complications
- Outcome indicators
- the health-related quality of life
- discrepancies in medication use
- the role of the different health care providers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2012
Shorter than P25 for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 6, 2012
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedJuly 19, 2017
July 1, 2017
11 months
March 1, 2012
July 18, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Quality of life
Quality of life will be investigated with the HPN-QoL(r) or FACIT-G (r).
2 years
Number of catheter related infections
2 years
Eligibility Criteria
Adult HPN patients with peritoneal carcinomatosis with intestinal occlusion or with crohn's disease, radiation enteritis, chronic diarrhea, intestinal lymphomas.
You may qualify if:
- Patients in Flanders who speak Dutch, are older then 18 years and are able to give an informed consent.
You may not qualify if:
- Patients who are younger then 18 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
- Ziekenhuis Netwerk Antwerpen (ZNA)collaborator
- AZ Sint-Lucas Bruggecollaborator
- Universiteit Antwerpencollaborator
- AZ Sint-Blasius Dendermondecollaborator
- Imelda Hospital, Bonheidencollaborator
- Ziekenhuis Oost-Limburgcollaborator
- AZ Damiaan, Oostendecollaborator
- H.-Hartziekenhuis Roeselare-Menen vzwcollaborator
- Universitair Ziekenhuis Brusselcollaborator
- University Hospital, Ghentcollaborator
- Jessa Hospitalcollaborator
Study Sites (13)
Antwerpen Middelheim
Antwerp, Belgium
UZA Antwerpen Edegem
Antwerp, Belgium
Imelda Ziekenhuizen Bonheide
Bonheiden, Belgium
AZ Sint-Lucas
Bruges, Belgium
University Centrum Brussel
Brussels, Belgium
AZ Sint Blasius Dendermonde
Dendermonde, Belgium
Ziekenhuis Oost Limburg
Genk, Belgium
AZ Sint Lucas en Volkskliniek
Ghent, Belgium
UZ Gent
Ghent, Belgium
Hasselt Jessa Ziekenhuizen
Hasselt, Belgium
Catholic University
Leuven, 3000, Belgium
AZ Damiaan
Ostend, Belgium
Heilig Hart vzw
Roeselare Menen, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
March 1, 2012
First Posted
March 6, 2012
Study Start
May 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
July 19, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share